Monitored Breathing Awareness Therapy for Insomnia Disorder in Older Adults
Not Applicable
Completed
- Conditions
- Insomnia
- Interventions
- Behavioral: MBAT
- Registration Number
- NCT03072017
- Lead Sponsor
- University of Pennsylvania
- Brief Summary
Insomnia can be a chronic problem that leads to significant daytime fatigue, stress and numerous negative health consequences including depression. Advanced Medical Electronics, in partnership with researchers are the University of Pennsylvania, propose developing an innovative, non-drug, low-risk, intervention that can be implemented on mobile devices for the treatment of insomnia.
- Detailed Description
Open-label pilot study in 20 older adults with insomnia (sleep onset latency\>30 minutes for at least 3 nights a week) with a two week intervention period.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- Sleep onset latency > 30 min for at least 3 nights per week
Exclusion Criteria
- Unable to perform tests due to inability to communicate verbally/blindness, inability to write and read in English (the study questionnaires are in English and do not exist in validated form for other languages).
- Cognitive impairment; cognitively impaired patients may not be able to comply with the protocol).
- History of a diagnosed non-insomnia sleep disorder, such as sleep apnea or circadian rhythm disorder
- Upper extremity motor impairment that would preclude MBAT therapy (e.g., quadriplegia).
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description MBAT MBAT Monitored breathing awareness therapy administered using a mobile device on a nightly basis during sleep onset.
- Primary Outcome Measures
Name Time Method Sleep onset latency two weeks Time to fall asleep
- Secondary Outcome Measures
Name Time Method